Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology

Background Variation in the incidence rate in epidemiological studies on amyotrophic lateral sclerosis (ALS) may be due to a small population size and under ascertainment of patients. The previously reported incidence decline in the elderly and a decrease in the male:female ratio in postmenopausal age groups have yet to be confirmed. Methods ALS epidemiology in a large population based register in The Netherlands was studied between 1 January 2006 and 31 December 2009, and applied capture–recapture methodology in separate age and gender groups to adjust for the number of unobserved patients. Results 1217 incident patients were observed, and a capture–recapture incidence of 2.77 per 100 000 person-years (95% CI 2.63 to 2.91). Prevalence on 31 December 2008 was 10.32 per 100 000 individuals (95% CI 9.78 to 10.86). The incident cohort had a higher median age at onset (63.0 vs 58.1 years) and more bulbar onset patients (30.0% vs 19.1%) compared with the prevalent cohort. Incidence and prevalence peaked in the 70–74 year age group followed by a rapid decline in older age. The male:female ratio in the premenopausal age group (1.91, 95% CI 1.32 to 2.79) was not significantly higher than that in the postmenopausal age group (1.50, 95% CI 1.34 to 1.67). Conclusion The marked difference in patient characteristics between incident and prevalent cohorts underscores the importance of including incident patients when studying susceptibility or disease modifying factors in ALS. The incidence decline in the elderly may suggest that ALS is not merely the result of ageing. Absence of a significant postmenopausal drop in the male:female ratio suggests that the protective role of female sex hormones in ALS is limited.

[1]  R. Forbes,et al.  The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. , 2004, Age and ageing.

[2]  O. Hardiman,et al.  Computerized databases for ALS incidence calculations: ready, steady, but don’t go yet , 2009, European Journal of Neurology.

[3]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[4]  C. Armon An Evidence-Based Medicine Approach to the Evaluation of the Role of Exogenous Risk Factors in Sporadic Amyotrophic Lateral Sclerosis , 2003, Neuroepidemiology.

[5]  J. De Pedro-Cuesta,et al.  An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. , 1996, Neuroepidemiology.

[6]  R R Regal,et al.  The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. , 1992, American journal of epidemiology.

[7]  D. G. Chapman Some properties of the hypergeometric distribution with applications to zoölogical somple censuses , 1951 .

[8]  J. Alappat ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.

[9]  E. Beghi,et al.  Incidence of ALS in Lombardy, Italy , 2007, Neurology.

[10]  M. Vinceti,et al.  Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. , 1996, Neuroepidemiology.

[11]  R. Palm,et al.  Motor Neuron Disease and Heavy Manual Labor: An Epidemiologic Survey of Värmland County, Sweden , 1984 .

[12]  S. Shimohama,et al.  Protection of cultured spinal motor neurons by estradiol , 2000, Neuroreport.

[13]  O. Hardiman,et al.  An all‐Ireland epidemiological study of MND, 2004–2005 , 2009, European journal of neurology.

[14]  Mulder Dw Clinical limits of amyotrophic lateral sclerosis. , 1982 .

[15]  A. Alpérovitch,et al.  Rising amyotrophic lateral sclerosis mortality in France 1968–1990: Increased life expectancy and inter-disease competition as an explanation , 1994, Journal of Neurology.

[16]  A. Hudson,et al.  The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada , 1986, Neurology.

[17]  S. Rudnicki Estrogen replacement therapy in women with amyotrophic lateral sclerosis , 1999, Journal of the Neurological Sciences.

[18]  E. Beghi,et al.  Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  A. Al-Chalabi,et al.  Amyotrophic Lateral Sclerosis in South-East England: A Population-Based Study , 2007, Neuroepidemiology.

[20]  R. Luiz,et al.  Evaluation of childhood acute leukemia incidence and underreporting in Brazil by capture-recapture methodology. , 2009, Cancer epidemiology.

[21]  J. Annegers,et al.  Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. , 1991, Archives of neurology.

[22]  R. Forbes,et al.  The incidence of motor nueron disease in Scotland , 2007, Journal of Neurology.

[23]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). , 2007, Neuroepidemiology.

[24]  Janel O. Johnson,et al.  Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients , 2010, Proceedings of the National Academy of Sciences.

[25]  R. Ophoff,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[26]  G. Schellenberg,et al.  Dementia and Alzheimer disease incidence: a prospective cohort study. , 2002, Archives of neurology.

[27]  O. Hardiman,et al.  Incidence and prevalence of ALS in Ireland, 1995–1997 , 1999, Neurology.

[28]  P. B. Christensen,et al.  Incidence and prevalence of motor neuron disease in two Danish counties. , 1989, Neuroepidemiology.

[29]  R R Regal,et al.  Capture-recapture methods in epidemiology: methods and limitations. , 1995, Epidemiologic reviews.

[30]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[31]  L. H. van den Berg,et al.  What we truly know about occupation as a risk factor for ALS: A critical and systematic review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[32]  T. Koepsell,et al.  Incidence of amyotrophic lateral sclerosis in three counties in western Washington state , 1996, Neurology.

[33]  C. Whitty,et al.  Prospective, National Clinical and Epidemiologic Study on Imported Childhood Malaria in the United Kingdom and the Republic of Ireland , 2010, The Pediatric infectious disease journal.

[34]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[35]  W. Haas,et al.  INCIDENCE RATE OF NONTUBERCULOUS MYCOBACTERIAL DISEASE IN IMMUNOCOMPETENT CHILDREN: A PROSPECTIVE NATIONWIDE SURVEILLANCE STUDY IN GERMANY , 2009, The Pediatric infectious disease journal.

[36]  A. Weir,et al.  Motor Neuron Disease: A Disease of Old Age , 1993, Scottish medical journal.

[37]  L. Goldstein,et al.  The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[38]  O. Hardiman,et al.  Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004 , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  M. Druet‐Cabanac,et al.  Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Uruguay: A Population-Based Study , 2008, Neuroepidemiology.

[40]  P. Preux,et al.  Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007 , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[41]  M. Thun,et al.  Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.